MARKET

MMED

MMED

MINIMED GROUP INC
NASDAQ
14.94
-0.12
-0.76%
Opening 11:34 07/10 EDT
OPEN
15.05
PREV CLOSE
15.05
HIGH
15.37
LOW
14.81
VOLUME
204.26K
TURNOVER
--
52 WEEK HIGH
20.48
52 WEEK LOW
10.65
MARKET CAP
4.19B
P/E (TTM)
-11.5088
1D
5D
1M
3M
1Y
5Y
1D
Medtronic: Guidance Built To Be Beaten - Buy
Seeking Alpha · 5h ago
MiniMed Group director Scott T. Cundy files initial beneficial ownership statement
PUBT · 3d ago
Weekly Report: what happened at MMED last week (0629-0703)?
Weekly Report · 4d ago
MiniMed Group (MMED) Stock Faces 333 Million Annual Loss Testing Bullish Growth Narratives
Simply Wall St · 07/01 22:40
MiniMed FY26 net loss widens to $317 million; net sales rise 14.2% to $3.1 billion
PUBT · 06/29 16:11
MiniMed adds David Endicott, Linnea Burman to board of directors
TipRanks · 06/29 13:10
MiniMed adds Alcon CEO David Endicott to board
PUBT · 06/29 13:04
MINIMED APPOINTS ALCON CEO DAVID ENDICOTT AND LINNEA BURMAN TO ITS BOARD OF DIRECTORS
Reuters · 06/29 13:04
More
About MMED
MiniMed Group, Inc. is a medical technology company, which develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes. Its fully integrated system addresses pain points for people with diabetes (PWD): health outcomes and complexity of diabetes management. The MiniMed 780G is its flagship AID system. The MiniMed 780G system uses its SmartGuard dosing algorithm technology, which automatically delivers basal insulin and auto-correction doses every five minutes based on sensor glucose readings. The MiniMed 780G consists of the MiniMed 780G insulin pump, the Simplera Sync CGM sensor, and the instinct sensor. Its platform of clinically effective solutions for PWD requiring insulin therapy includes Automated Insulin Delivery (AID) Systems and a Smart Multiple Daily Injection (MDI) System. Its pipeline products are the MiniMed Flex, screenless insulin pump, next-generation Vivera dosing algorithm, and MiniMed Fit patch pump with extended wear.

Webull offers MiniMed Group, Inc. stock information, including NASDAQ: MMED real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MMED stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MMED stock methods without spending real money on the virtual paper trading platform.